Answers are grounded in this paper and cite their sources.
Erbium activated PbO-ZnO tellurite glasses ((70TeO(2)-(30-x)ZnO-xPbO)(0.99)-(Er(2)O(3))(0.01) (TZPE), (x = 5, 10, 15, 20)) were prepared by a melt quenching process and studied by optical absorption, luminescence, Raman and x-ray absorption spectroscopy measurements as a function of the PbO/ZnO ratio. The glass structure, as monitored by Raman scattering, shows important changes with the PbO/ZnO ratio, attributed to a glass former action of PbO. The local environment of Er(3+) ions, as measured by extended x-ray absorption spectroscopy, does not appreciably change as regards the first oxygen shell. However, the intensity of the optical transitions is quite sensitive to the PbO/ZnO ratio, indicating a progressive increase of the site symmetry with the PbO content. The emission probability and radiative lifetime of several excited states of Er(3+) ions were calculated using Judd-Ofelt analysis.
No takes yet. Share an insight, caveat, or question.
Ramamoorthy et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: